• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Reltio Raises $22M to Fuel Healthcare Data Management Apps

by Fred Pennic 07/28/2016 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Reltio Raises $22M to Fuel Healthcare Data-Driven Apps

Reltio, a Redwood Shores, CA-based creator of new “data-driven apps” delivered through a modern data management platform  has raised $22M in Series B funding led by New Enterprise Associates (NEA). The round also included participation from existing investors  Crosslink Capital and .406 Ventures bringing Reltio’s total venture funding to $32M to date. The company plans to utilize the recent to strengthen its footprint in modern data management through accelerated hiring of talented individuals across all groups, and continued expansion into global markets.

With the emergence of IDNs, ACOs, MCOs the approach to healthcare is evolving. The focus in on overall well being and quality of life than just one-time treatment. This requires a new patient-centric approach with a complete understanding of patient’s needs, behaviors, and preferences and focus on building long-term relationships. 

Reltio’s core product, Reltio Cloud provides healthcare and life sciences organizations with a modern data management platform that enables a complete understanding of your patients, physicians, and other partners across all clinics and facilities, with real-time visibility into relationships, healthcare metrics, and utilization trends by the site of care.

Reltio also delivers a complete view of information for managed markets teams so they can optimize their activities and achieve better outcomes. Highlights include:

– Complete payer hierarchies down to the plan level

– Detailed views of payers, channels, regions, and plans

– Insight into formulary, competitive products and tiers

– Cross correlation of product metrics and longitudinal stats

– Identification and management of Pharmacy Benefit Manager details and associated contracts

Reltio founder, Manish Sood co-authored the patent that revolutionized master data management, and his previous work has become foundational to practices routinely in use today. Cloud-based Reltio data-driven app are currently available for every function and use case within a life sciences organization, including Affiliation Management, HCP/HCO Data Management, Product Data Management, Plan and Payer Management, Clinical Trial Site Investigator Management and Key Account Management.

In just the first half of 2016, Reltio has added leading companies in healthcare & life sciences with the recent signing of three of the top ten global pharmaceutical organizations, and an alliance with IMS Health to power IMS Health’s flagship IMS One Platform.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Reltio

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |